These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21216014)

  • 1. Metabolic syndrome and serum homocysteine in patients with bipolar disorder and schizophrenia treated with second generation antipsychotics.
    Vuksan-Ćusa B; Jakovljević M; Sagud M; Mihaljević Peleš A; Marčinko D; Topić R; Mihaljević S; Sertić J
    Psychiatry Res; 2011 Aug; 189(1):21-5. PubMed ID: 21216014
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between C-reactive protein and homocysteine with the subcomponents of metabolic syndrome in stable patients with bipolar disorder and schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljevic M; Peles AM; Jaksic N; Mihaljevic S; Zivkovic M; Mikulic SK; Jevtovic S
    Nord J Psychiatry; 2013 Oct; 67(5):320-5. PubMed ID: 23228159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population.
    Lee NY; Kim SH; Cho B; Lee YJ; Chang JS; Kang UG; Kim YS; Ahn YM
    Prog Neuropsychopharmacol Biol Psychiatry; 2010 Oct; 34(7):1243-9. PubMed ID: 20599461
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differences in cholesterol and metabolic syndrome between bipolar disorder men with and without suicide attempts.
    Vuksan-Cusa B; Marcinko D; Nad S; Jakovljević M
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Feb; 33(1):109-12. PubMed ID: 19026707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of diabetes and the metabolic syndrome in a sample of patients with bipolar disorder.
    van Winkel R; De Hert M; Van Eyck D; Hanssens L; Wampers M; Scheen A; Peuskens J
    Bipolar Disord; 2008 Mar; 10(2):342-8. PubMed ID: 18271914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein and metabolic syndrome in patients with bipolar disorder compared to patients with schizophrenia.
    Vuksan-Cusa B; Sagud M; Jakovljević M
    Psychiatr Danub; 2010 Jun; 22(2):275-7. PubMed ID: 20562761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of vascular disease in metabolic syndrome using three proposed definitions.
    Athyros VG; Ganotakis ES; Elisaf MS; Liberopoulos EN; Goudevenos IA; Karagiannis A;
    Int J Cardiol; 2007 Apr; 117(2):204-10. PubMed ID: 16854482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relation between weight gain and clinical improvement: is there a metabolic threshold for second generation antipsychotics?
    Sharma E; Rao NP; Venkatasubramanian G; Behere RV; Varambally S; Sivakumar PT; Gangadhar BN
    Psychiatry Res; 2011 Mar; 186(1):155. PubMed ID: 20691482
    [No Abstract]   [Full Text] [Related]  

  • 9. Equally increased risk for metabolic syndrome in patients with bipolar disorder and schizophrenia treated with second-generation antipsychotics.
    Correll CU; Frederickson AM; Kane JM; Manu P
    Bipolar Disord; 2008 Nov; 10(7):788-97. PubMed ID: 19032710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Easy and low-cost identification of metabolic syndrome in patients treated with second-generation antipsychotics: artificial neural network and logistic regression models.
    Lin CC; Bai YM; Chen JY; Hwang TJ; Chen TT; Chiu HW; Li YC
    J Clin Psychiatry; 2010 Mar; 71(3):225-34. PubMed ID: 19814949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between metabolic syndrome and cognition in patients with schizophrenia.
    Lindenmayer JP; Khan A; Kaushik S; Thanju A; Praveen R; Hoffman L; Cherath L; Valdez G; Wance D
    Schizophr Res; 2012 Dec; 142(1-3):171-6. PubMed ID: 23106932
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in a French cohort of patients with bipolar disorder: results from the FACE-BD cohort.
    Godin O; Etain B; Henry C; Bougerol T; Courtet P; Mayliss L; Passerieux C; Azorin JM; Kahn JP; Gard S; Costagliola D; Leboyer M;
    J Clin Psychiatry; 2014 Oct; 75(10):1078-85; quiz 1085. PubMed ID: 25373115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic syndrome and aerobic fitness in patients with first-episode schizophrenia, including a 1-year follow-up.
    Nyboe L; Vestergaard CH; Moeller MK; Lund H; Videbech P
    Schizophr Res; 2015 Oct; 168(1-2):381-7. PubMed ID: 26278336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of Hunperdal Richter in psychiatry].
    Magyar GI; Fadgyas I
    Neuropsychopharmacol Hung; 2009 Jun; 11(2):111-5. PubMed ID: 19827319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prevalence of metabolic syndrome in patients with bipolar disorder.
    Garcia-Portilla MP; Saiz PA; Benabarre A; Sierra P; Perez J; Rodriguez A; Livianos L; Torres P; Bobes J
    J Affect Disord; 2008 Feb; 106(1-2):197-201. PubMed ID: 17631970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of antipsychotic-induced weight gain: prospective naturalistic study of the effectiveness of a supervised exercise programme.
    Poulin MJ; Chaput JP; Simard V; Vincent P; Bernier J; Gauthier Y; Lanctôt G; Saindon J; Vincent A; Gagnon S; Tremblay A
    Aust N Z J Psychiatry; 2007 Dec; 41(12):980-9. PubMed ID: 17999270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
    Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
    Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolic syndrome and adverse clinical outcomes in patients with bipolar disorder.
    Bai YM; Li CT; Tsai SJ; Tu PC; Chen MH; Su TP
    BMC Psychiatry; 2016 Dec; 16(1):448. PubMed ID: 27978821
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia.
    Mulder H; Franke B; van der-Beek van der AA; Arends J; Wilmink FW; Scheffer H; Egberts AC
    J Clin Psychopharmacol; 2007 Aug; 27(4):338-43. PubMed ID: 17632216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of baseline lipid monitoring in patients prescribed second-generation antipsychotics during their index hospitalization: a retrospective cohort study.
    Laundon W; Muzyk AJ; Gagliardi JP; Christopher EJ; Rothrock-Christian T; Jiang W
    Gen Hosp Psychiatry; 2012; 34(4):380-4. PubMed ID: 22554429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.